Advanced prostate cancer.
Keep browsing
Proclarix® is CE marked, intended for in vitro diagnostic use and indicated for prostate cancer diagnosis in patients with normal digital rectal exam (DRE), enlarged prostate volume and elevated levels of PSA at 2-10 ng/ml.
Management of acute and chronic symptoms of chemotherapy-induced sensory peripheral neuropathy.
Xemperia flag-ship project is a PCR-based blood test for breast cancer screening.The technology can be adapted to other cancers, immune, inflammatory and cardiovascular diseases.Xemperia's pipeline also includes DNA based nansensors for the ultrasensitive detection of nucleic acids.
